# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Roth MKM analyst Craig Irwin reiterates Blue Bird (NASDAQ:BLBD) with a Buy and raises the price target from $35 to $40.
Needham analyst Chris Pierce reiterates Blue Bird (NASDAQ:BLBD) with a Buy and maintains $44 price target.
Needham analyst Chris Pierce initiates coverage on Blue Bird (NASDAQ:BLBD) with a Buy rating and announces Price Target of $44.
The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering.
Barclays analyst Adam Seiden maintains Blue Bird (NASDAQ:BLBD) with a Overweight and raises the price target from $25 to $35.
Roth MKM analyst Craig Irwin maintains Blue Bird (NASDAQ:BLBD) with a Buy and raises the price target from $26 to $35.